TrialBritish journal of cancer2012

Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium.

T M Beer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.